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Staphylococci pretreated with subminimal inhibitory concentrations (subMIC) of cell-wall
active antibiotics exhibit increased susceptibility to killing by human polymorphonuclear
leukocytes (PMNs), even when phagosome information is impaired by the mold metabolite,
cytochalasin B. To investigate the role of specific bacterial factors in the process, studies were
carried out with organisms lacking catalase (streptococci) or cell-wall autolytic enzymes and
compared to findings with Staphylococcus aureus 502A. Neutrophil factors were studied using
inhibitors, oxygen radical scavengers, myeloperoxidase (MPO)-deficient PMNs, or PMNs from a
patient with chronic granulomatous disease (CGD).
Documentation of the enhanced susceptibility of the streptococcal strains to killing by PMNs
following subMIC penicillin pretreatment required the use of cytochalasin B. Enhancement of
killing occurred independent of the presence or absence of bacterial autolysins or catalase.
SubMIC penicillin pretreatment ofS. pneumoniae R36A specifically promoted the susceptibility
of these organisms to killing by myeloperoxidase (MPO)-mediated mechanisms (enhancement
lost using MPO-deficient or azide-treated cells). Factors other than MPO or toxic oxygen
products generated by the PMN respiratory burst are responsible for enhanced killing of
penicillin-pretreated S. aureus 502A (enhancement preserved using MPO-deficient, azide-
treated, or chronic granulomatous disease patient cells).
These studies define methods to study the interaction of antimicrobial agents and PMNs in the
killing of microorganisms. They also demonstrate that penicillin treatment can change the
susceptibility ofgram-positive cocci to the action ofspecific PMN microbicidal mechanisms. The
mechanism of the enhancement appears to be bacterial strain-dependent and not predictable by
bacterial autolysin or catalase activity.
INTRODUCTION
We have previously shown [1,2] that laboratory and clinical isolates of S. aureus
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pretreated with subminimal inhibitory concentrations (subMIC) of cell-wall active
antibiotics (penicillin, vancomycin), but not ribosomally activedrugs such as gentami-
cin, are more susceptible to killing by human polymorphonuclear leukocytes (PMNs).
This increased susceptibility is present even when bacterial uptake and phagosome
formation of the PMN are inhibited by cytochalasin B. In these experiments, all
penicillin-treated bacteria which were ingested by or bound to normal or cytochalasin
B-treated PMNs were killed as opposed to only a fraction ofthe untreated bacteria.
S. aureus are catalase-positive organisms which contain autolytic enzymes that
might be triggered by penicillin [3]. In order to assess the role ofbacterial catalase, as
well as the role of autolysins in the enhanced killing of cell-wall active antibiotic-
treated bacteria, experiments were performed with three well-characterized strains of
streptococci and the results compared to similar experiments with S. aureus 502A.
Streptococcus pneumoniae R36A, a rough "wild-type" pneumococcus, was chosen
since it is catalase-negative and has an autolysin-defective mutant [4,5], and the
absence of a capsule avoided alterations in phagocytosis and killing due to loss of
capsular polysaccharide following antibiotic pretreatment. Streptococcus sanguis
strain "Wicky" is an autolysin-defective Lancefield group H hemolytic streptococcus.
It shares with the autolysin-defective R36A pneumococcus the feature of antibiotic
tolerance; that is, penicillin G inhibits growth in low concentrations but does not cause
lysis and produces only a minor loss in viability during pretreatment [6]. To examine
the role of PMN oxidative mechanisms in the killing process, studies were performed
with cells from patients with chronic granulomatous disease (CGD) and myeloperoxi-
dase (MPO) deficiency as well as normal PMNs treated with sodium azide. Further-
more, avariety ofoxygen reduction product scavengers were examined for their ability
to modify killing ofpenicillin-pretreated S. aureus 502A.
Similar to the findings with staphylococci, penicillin pretreatment enhanced the
killing of all three streptococcal strains by PMNs in the presence of cytochalasin B.
The basis of this enhancement differed, however, with respect to mechanisms
employed by the PMNs and the bacterial species studied. Oxidative mechanisms
appear essential for enhanced killing ofS.pneumoniae; non-oxidative mechanisms are
more important in the killing ofS. aureus and the autolysin-defective S. sanguis var.
Wicky. These studies define an approach to investigating potentially important
interactions between antibiotics and PMNs in the killing ofdifferent bacteria.
MATERIALS AND METHODS
Reagents
Cytochalasin B was purchased from Aldrich Chemical Co., Inc., Milwaukee, WI,
dissolved in dimethyl sulfoxide (DMSO; Sigma Chemical Co., St. Louis, MO) to a
concentration of 2.5 mg/ml and frozen at -200C. It was used in the experimental
suspensions at a final concentration of 5 ,ug/ml and fresh aliquots were thawed and
used daily. '4C-labeled mixed L-amino acids and Aquasols for liquid scintillation
counting werepurchased from the New England NuclearCo., Boston, MA. Trypticase
soy agar (TSA) and broth (TSB) werepurchased from Baltimore Biological Laborato-
ries, Cockeysville, MD. Hank's balanced salt solution (HBSS) came from Flow
Laboratories, Rockville, MD. 3 percent dextran in saline and penicillinase were
purchased from Sigma Chemical Co. Penicillin G was obtained from E.R. Squibb and
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Son, Inc., Princeton, NJ. 12 x 75 mm pyrex borosilicate tubes were purchased from
Corning Glass Works, Corning, NY. Normal human serum was obtained from the
clotted blood of healthy consenting volunteers, pooled, separated into aliquots, and
stored at -700C until used.
Microorganisms
Streptococcuspneumoniae, strain R36A (wild type, Rockefeller University Labora-
tory stock) an autolysin-defective mutant derivative of the R36A strain [4,5] (Cwl),
and the group H hemolytic Streptococcus sanguis, strain Wicky, were kindly supplied
by Drs. Diane Horne and Alexander Tomasz ofthe Rockefeller University.
Stocks of each strain were frozen without aeration with 10 percent glycerol in C
medium supplemented with 0.1 percent yeast extract [7] also supplied by Drs. Horne
and Tomasz. All of the above organisms are catalase-negative. The coagulase and
catalase-positive, penicillinase-negative Staphylococcus aureus H.R. Shinefield
502A, was used in a portion of the experiments [1]. The minimal inhibitory
concentrations (MIC) of all organisms were determined by a previously described
method [8]. TheS.pneumoniae R36A was found to have a MIC forpenicillin G of.015
,cg/ml, the autolysin-defective mutant of0.2 ,ucg/ml, the Wicky strain ofS. sanguis,
of0.13 ,ucg/ml, and the S. aureus 502A, of .075 ,ucg/ml broth.
Leukocyte Preparation
PMNs were separated from the heparinized (10 U/ml) peripheral blood ofhealthy
consenting volunteers, from a patient with CGD [9], and a patient with leukocyte
MPO deficiency [10]. The blood was processed by centrifugation on Ficoll-Hypaque
and dextran sedimentation, with hypotonic lysis of the erythrocytes as previously
described [11]. The leukocyte-rich supernatants were centrifuged at 150 g for seven
minutes at 40C, the cells enumerated by hemocytometer and resuspended in antibiotic-
free HBSS to a final concentration of 5 x 106/ml. PMNs comprised 80 to 95 percent
ofthe final cell population and constituted 98 percent ofthe phagocytic cells.
Preparation ofBacteria
Samples were taken from each stock culture, diluted 1:100, and incubated in fresh
TSB at 370C for two hours (three hours for S. sanguis) to place the bacteria in the
logarithmic growth phase. At this point, each bacterialsuspension wasdivided into two
equal aliquots, and penicillin G, at a final concentration of'/4 to l/32 of the MIC of the
respective bacteria, was added to one and sterile TSB to the other (control). Both
bacterial suspensions were allowed to grow for another two hours (three hours for S.
sanguis). At the end of that period, the bacteria were removed from the antibiotic-
containing or control broth by centrifugation at 2,200 g for ten minutes, washed by
suspension in MHS, recentrifuged, and finally resuspended in HBSS. They were
adjusted to 2.5 x 108/ml viable counts aftergentle sonication (20,000 Hz outputof35
W for ten seconds, Brown Sonic Power Co., Danbury, CT). This amount ofsonication
was sufficient to disrupt large clumps of staphylococci and to break the streptococcal
chains into diplococci or short chains of four to six organisms, which were equivalent
for untreated and penicillin-treated organisms. The bacterial inoculum was standard-
ized visually by turbidity. When desired, 14C labeling of bacterial proteins wasISTURIZ ET AL.
achieved by performing the four-hour (or six-hour for S. sanguis) incubation in the
presence of 2-3 ,Ci (3,000,000 CPM) of '4C-labeled mixed L-amino acids [1].
Bactericidal Assays
1 ml suspensions containing 2.5 x 106 PMN and approximately 2.5 x I07 bacteria
were incubated in HBSS at 370C in the presence of 1 percent albumin and 10 percent
serum as a source of opsonins. When cytochalasin B was used, the cells were
preincubated with 5 ,ug/ml of the compound for ten minutes at 370C before the
addition of the bacteria. The bacterial inoculum was equalized for treated and
untreated organisms as determined by Petroff-Hauser chamber counting.
Initial samples were taken immediately after addition of the bacteria to the tubes,
which were then capped and rotated at 370C. Killing ofthe inoculum was measured at
various times by a previously described method [1, 11 ]. The percentage ofsurvival was
calculated by dividing the number ofcolony-forming units at each time by the number
at 0 minutes and then multiplying by 100. From this figure, the percentage of killing
could be calculated by subtraction from 100. Appropriate cell-free controls were run
for each assay.
Phagocytosis Assays
The uptake (binding plus phagocytosis) of viable '4C-labeled bacteria by the cells
was assessed as previously described [1,11]. Leukocytes in a final concentration of
2.5 x 106 ml were placed in 12 x 75 mmglass borosilicate tubes with HBSS, 1 percent
albumin, and 10 percent serum for opsonization. After preincubation for ten minutes
at 37 OC, the bacterial suspensions (2.5 x 107) were added to the mixture at 20-second
intervals. The capped tubes were allowed to rotate for 30 minutes, at which time
phagocytosis was stopped by flooding the suspensions with 2 ml of ice-cold HBSS
containing 10 percent fetal calfserum and 0.2 M NaF and immediately placing them
on ice. Preparation of the cell suspension for radioactive counting was as previously
described [1]. The percentage of organisms associated with the cells could be
calculated by dividing cell-associated counts per minute by the counts per minute in
the original inoculum and multiplying by 100. Similarly, the number of bacteria
associated with the cells could be obtained from calculations ofthe specific activity of
the radiolabeled organisms.
On multiple occasions, the bactericidal and phagocytosis assays were run simulta-
neously with the same inoculum. In experimental and control suspensions, the fraction
of bacteria associated with the cells that were killed could thus be calculated. All the
experiments were run in duplicate as well as with simultaneous cell-free controls.
Statistical Analysis
The student t-test for paired samples was used for analysis. Values ofp < 0.05 for
differences between control and experimental preparations were considered statisti-
cally significant.
RESULTS
Growth andAmino AcidLabelingofPneumococci andS. sanguis
Organisms incubated in the presence of l/4 to 1/32 the MIC ofpenicillin G multiplied
at the same rate as controls; for example, for wild-type pneumococcus, the bacterial
136KILLING OF PENICILLIN-TREATED GRAM-POSITIVE COCCI BY PMNS
TABLE 1
Effect of SubMIC Penicillin (PCN) Pre-Treatment on Uptake and Killing of S. pneumoniae R36A by
Normal and Cytochalasin B-Treated PMNs'
Untreated Bacteria 1/4 MIC PCN-Treated Bacteria
Normal Cells
% uptake (7) 60.6 ± 3.78 60.3 ± 4.44
% killed (8) 78.5 ± 5.56 79.9 ± 5.08
Cyto B-Treated Cells
% uptake (9) 43.41 ± 3.29 43.18 ± 2.84
% killed (16) 22.72 ± 4.67 45.6 ± 4.51b
aData are expressed as the mean ± SEM of the number of experiments shown in parentheses. The
incubation period was 30 minutes. The inoculum measured an average of 2.08 x 107 ± 0.18 vs. 2.05 x
107 ± 2.2 bacteria for untreated vs. treated organisms, respectively.
bp < 0.01 student's t-test for paired samples in comparison with simultaneously run untreated organisms
population reached at two hours averaged 1.89 x 107 for the bacteria incubated in
antibiotic-free media and 2.03 x 107 for the organisms exposed to 1/4 MIC concentra-
tion of the penicillin (n = 16). The subsequent viability of both control and treated
organisms in suspensions incubated without PMNs was equivalent as long as 1 percent
albumin was present in the medium. Similar findings were noted for the autolysin-
defective mutant and the S. sanguis strain. In the experiments using 14C amino acid
labeling of bacteria, wild-type pneumococci treated with 1/4 the MIC of penicillin G
accumulated a slightly higher mean number of counts per minute per 106 bacteria
(32.06) than untreated bacteria (26.14; n = 12; p > .2). This difference was less than
our previous findings with S. aureus 502A [1].
While the S. sanguis strain did not replicate as quickly as the pneumococci,
incubation in subMIC antibiotic concentrations of penicillin, up to 1/4 MIC, did not
affect growth or labeling with 14C amino acids. Similar findings were noted for the
autolysin-defective pneumococcal mutant.
KillingofPneumococcus (R36A) by Normal and Cytochalasin B-Treated PMNs
Both normal and cytochalasin B-treated PMNs were used in the bactericidal-
phagocytosis assays. Sinceviabilityofpneumococci was found tobepoor in HBSS with
10 percent pooled human serum, 1 percent albumin was added to all bacterial-cell
suspensions. These conditions did not alter phagocytic or bactericidal ability of the
PMNs. Furthermore, survival oftreated and untreated organisms in this medium was
equivalent.
As with S. aureus [1], most bacterial uptake and killing occurred in the first 30
minutes; hence, since incubation for longer time periods did not alter the differences
[1] all data presented are for a 30-minute time period. Pretreatment for two hours with
1/4 MIC of penicillin had no significant effect on phagocytosis or killing of the rough
pneumococcus by normal PMNs. Essentially all organisms which became cell-
associated were killed with or without penicillin pretreatment (Table 1); in fact, the
percentage killed as measured by pour plate technique was higher than that taken up
as calculated by cell-associated 14C amino acid counts. In contrast, treatment of the
cells with cytochalasin B significantly (and equally) reduced the uptake of both
untreated and penicillin-pretreated bacteria (p < .05; t-test). Relative to phagocyto-
sis, killing was impaired for only the untreated bacteria, however (p < .01 for paired
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TABLE 2
Effect of subMIC Penicillin (PCN) Pretreatment on Uptake and Killing of Lysin-Defective
Streptococci by Cytochalasin B-Treated PMNsa
Untreated Bacteria 1/4 MIC PCN-Treated Bacteria
S. pneumoniae R36A Lysin-Defective Strain
% uptake (5) 65.9 ± 4.9 66.4 ± 5.4
% killed (5) 23.4 ± 3.5 40.8 ± 3.3b
S. sanguis, "Wicky" Strain
% uptake (3) 63.4 ± 10.6 66.6 ± 10.3
% killed (3) 24.2 ± 3.1 51.0 ± 1 1.6b
aData are expressed as the mean ± SEM of the number of experiments shown in parentheses. The
inoculum was equivalent for treated or untreated organisms. The incubation period was 30 minutes.
bp < 0.01 student's t-test forpairedsamples incomparison withsimultaneously run untreatedorganisms
samples). In the presence of cytochalasin B, as with normal PMNs, all treated
pneumococci taken up by the cells were killed vs. only a fraction (52 percent) of the
untreated organisms.
In experiments not shown, pretreatment with as little as 1/8 of the MIC resulted in
augmented killing by cytochalasin B-treated PMNs. The antibiotic effect was lost at
1/16 of the MIC or less. The effect was also abolished when penicillinase was added to
thepenicillin-containing mediumduring the pretreatment period.
Phagocytosis andKillingofLysin-Defective Pneumococcus andS. sanguis, Strain
Wicky
Similar to the wild-type pneumococcus R36A, no enhancement of killing of the
antibiotic-treated lysin-defective pneumococcus or S. sanguis was observed when
normal PMNs were used, since essentially all bacteria taken upby the cells were killed
regardless of pretreatment. Treatment of the cells with cytochalasin B inhibited
bacterial uptake equally for treated and non-penicillin treated organisms, and thus
cytochalasin B-treated cells were used for subsequent comparative studies. Table 2
compares the cellular uptake and killing of the autolysin-defective pneumococcal
strain and the Wicky strain of Streptococcus sanguis. In these experiments, the
bacterial inoculum of the lysin-defective pneumococcus was lower than that of the
wild-type strain, which accounts in part for the greater percentage ofuptake than that
found for wild-type organisms and shown in Table 1. Penicillin pretreatment approxi-
mately doubled killing of both of the autolysin-defective strains; the percentage of
organisms killed was less than that taken up, however, in contrast to the wild-type
R36A pneumococcus and our previous findings with S. aureus 502A [1].
Role ofPMN Oxidative Pathways in KillingPenicillin-Treated Gram-Positive Cocci
To assess the role of various oxidative pathways in the killing of untreated and
penicillin-pretreated gram-positive cocci, studies employing sodium azide or exposure
to MPO-deficient or CGD PMNs were carried out.
The addition of sodium azide (1 mM concentration) to the incubation mixtures to
block MPO activity did not significantly alter the uptake ofany ofthe bacterial strains
by cytochalasin B-treated PMNs (data not shown). In contrast, the effects ofazide on
bacterial killing were strain-dependent (Table 3). For example, azide reduced killing
of untreated pneumococci by a mean of 34.4 percent and that of the penicillin-
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TABLE 3




PMNs PCN Treatment S. aureus S. pneumoniae R36A S. sanguis
Control - 28.7 ± 1.9 (7) 25.6 ± 2.8 (4) 25.8 ± 2.2 (5)
+ 57.7 ± 4.0 (7)b 45.7 ± 8.1 (4)b 66.6 ± 6.9 (5)b
Azide-Treated - 26.0 ± 2.2 (4) 16.8 ± 2.7 (4) 15.2 ± 3.6 (5)
+ 46.6 ± 7.4 (4)b 20.2 ± 7.5 (4) 33.7 ± 11.3 (5)
MPO-Deficient - 14.0 (1) 19.6 (1)
+ 53.0 (1) 14.3
CGD - 18.0 ± 0.05 (2) 21.7 (1)
+ 31.7 ± 3.3 (2)b 24.6
aData are expressed as the mean ± SEM ofthe number ofexperiments shown in parentheses for multiple
experiments. Single values are shown for single experiments. The incubation period was 30 minutes.
bp < .05 paired t-test when compared to non-penicillin-treated controls
pretreated organisms by 55.7 percent. The net effect was to abolish the differences in
susceptibility to killing of these organisms created by exposure to the antibiotic.
Incubation of PMNs with azide reduced killing of untreated S. sanguis by a mean of
41 percent vs. 44.0 percent for penicillin-pretreated organisms. The net effect was to
retain the increase in susceptibility tokillingofantibiotic-exposed organisms, although
the absolute differences were reduced. When killing of S. aureus was studied with
azide-treated cells, a modest decrease in killing of penicillin-treated organisms was
observed, but the penicillin effect was retained.
Studies with cells from a patient with MPO deficiency and a second patient with
CGD confirmed the differences between mechanisms used to kill penicillin-pretreated
pneumococci and staphylococci. Theenhanced killing ofpenicillin-pretreated pneumo-
cocci was abolished when either MPO-deficient or CGD PMNs were employed. While
CGD- or MPO-deficient PMNs killed staphylococci less effectively than normal cells,
the differences in susceptibility to killing between penicillin-pretreated and untreated
organisms were retained.
The potential role of oxidative mechanisms in the killing of S. aureus was further
explored, using several oxygen reduction product scavengers in incubations with
cytochalasin B-treated cells. Augmented killing of penicillin-pretreated bacteria was
preserved in the presence of scavengers of02- (SOD), H202 (catalase), OH and '02
(catalase and SOD) (Table 4).
DISCUSSION
We have developed a model to study the effect of subMIC concentrations of
antibiotics on neutrophil killing of gram-positive cocci. The model is based on the
hypothesis that modification of particular bacterial target sites by antibiotics may
increasesusceptibility oftheseorganisms tophagocytosis or killing by PMNs. We have
shown that antibiotics which modify the cell wall of staphylococci rather than those
with an intracellular siteofaction are morelikely to increase susceptibility tokillingby
PMNs [1,2]. Presumably, the action of cell-wall active antibiotics creates a lesion in
the organism at a site which is readily accessible to the microbicidal products of the
cells. The use of doses of antibiotics which are below the minimal concentration
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TABLE 4
Effect of Oxygen Product Scavengers on Killing of S. aureus 502A by Cytochalasin B-Treated
PMNsa
Bacteria
Additions Untreated 1/4 MIC PCN-Treatedb
None (14) 29.3 ± 4.9 62.8 ± 2.8
SOD (50Ag/ml) (3) 27.5 ± 0.2 65.3 ± 4.6
Catalase (4,000,u/ml) (2) 26.5 ± 12.5 70.8 ± 3.6
Catalase + SOD (5) 33.1 ± 7.6 56.3 ± 10.0
aData expressed as mean ± SEM of percentage killed at 30 minutes. Numbers in parentheses represent
the number ofexperiments.
bAll values significantly greater than with untreated bacteria (p < .05, t-test)
required to inhibit growth has permitted a clearer distinction between antibiotic and
PMN effects. Modification of the surface ofS. aureus by pretreatment with cell-wall
active antibiotics increases their susceptibility to killing by PMNs to a point that
killing occurs with inhibition of phagosome formation and without modification of
bacterial uptake or phagocytosis by normal or cytochalasin B-treated cells [1].
S aureus are catalase-positive organisms which contain autolytic enzymes that
could be involved in the combined effect of antibiotic and neutrophil microbicidal
mechanisms. Furthermore, the presence ofcatalase could have modified the suscepti-
bility of these organisms to oxidative killing by PMNs [12]. To assess the role of
catalase and to determine a role for the autolysins in this model, we used catalase-
negative organisms, for which an autolysin-defective strain was available, and exposed
them to penicillin and PMNs in the same fashion as with S. aureus. Treatment of
streptococci with penicillin causes secretion ofcell-wall polymers into the surrounding
medium, including capsular polysaccharide [13,14]. These findings have been
observed with bold wild-type and lysin-defective pneumococcus [4,13,14]. The use of
rough strains of these organisms reduced the possibility that changes in killing by
PMNs following penicillin pretreatment could be ascribed to loss ofcapsular polysac-
charide and alterations in phagocytosis [15]. Since both bacterial uptakeand killing by
PMNs were measured simultaneously in the same preparation in most experiments, a
comparison could be made between both parameters and the fraction taken up-killed
could be calculated.
Pretreatment ofthe streptococcal strains with penicillin G atvarious fractions ofthe
MIC caused no appreciable change in their replication or incorporation of mixed
'4C-amino acids. Normal PMNs ingested and killed both treated and untreated
bacteria avidly, and no. effect of penicillin pretreatment could be observed. This
contrasted with our earlier findings with S. aureus 502A in which the native resistance
of these organisms to intracellular killing by normal cells was overcome by subMIC
penicillin pretreatment. The increase in the percentage of streptococcal organisms
killed above those measured to be taken up by the cells (refer to Table 1) could
represent extracellular killing as reported by Weiss et al. [16] or a failure to separate
cleanly intracellular aggregates of viable organisms to be counted as separate
colonies.
Cytochalasin B treatment of PMNs inhibits phagosome formation, but not the
ability of organisms to ahhere to phagocytic receptors [1,17] and to trigger a
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respiratory burst [18,19] and lysosomal degranulation [19]. Itoffers theopportunity to
segregate events which occur following binding of various stimuli to the cell surface
from those which are dependent upon phagosome formation. Consistent with previous
observations [1,17,20], when cells treated with cytochalasin B were used, cellular
uptakewas moderately and killingofuntreated bacteria markedly impaired. Cytochal-
asin B-treated PMNs took up opsonized untreated and penicillin-pretreated strepto-
cocci equally well, a finding we previously noted for staphylococci [1]. A significant
difference in killing could be demonstrated between penicillin-treated and untreated
bacteria, however, so that essentially all cell-associated penicillin-treated organisms
were killedvs. approximatelyone-halfofthe untreated cocci. These effects ofpenicillin
pretreatment were observed in both autolysin-replete and -deficient strains, thereby
excluding an important cooperative role for bacterial autolysins as mediators of the
effect with the PMN microbicidal mechanisms. Furthermore, the equivalent cellular
uptake of untreated and treated bacteria distinguishes these effects of penicillin
pretreatment from those reported for group A or B streptococci [15,21].
The neutrophil microbicidal mechanisms responsible for effecting the enhanced
killing of the pretreated organisms were explored, using cytochalasin B-treated cells,
concentrating in particular on the potential role for oxidative pathways. Sodium azide
was employed to inhibit the MPO activity of normal cells [22,23]. Furthermore, cells
from patients totally deficient in MPO activity or the ability to generate oxygen-
reduction products during phagocytosis (CGD) were also used. The results indicated
that oxidative pathways were important in mediating the enhanced killing of the
catalase-negative pneumococci since the effect was abrogated by azide and lost in both
MPO-deficient and CGD PMNs. SubMIC penicillin treatment thus rendered these
organisms specifically more susceptible to killing by the MPO-H202 microbicidal
system of the neutrophil. The enhancement was such that this system could operate
effectively against organisms bound to cells and not enclosed in phagosomes, the
consequence ofcytochalasin B treatment [1,17,18].
The precise nature ofthe target site modification created by penicillin pretreatment
which promoted this expression of the MPO-H202 system against pneumococci
remains to be elucidated. The possibilities range from better access ofMPO or H202 to
this target site, improved presentation of amino groups for chlorination reactions
[24,25] or iron centers for oxidative attack by hypochlorous acid [26], or some other
yet-to-be-defined mechanism.
Whatever the nature of this mechanism, it appears to operate independently of
microbial catalase, which is absent in pneumococci. Evidence forthis isprovided by the
observation that the related catalase-negative streptococcal species, S. sanguis, and S.
aureus, catalase-positive, both retained enhanced susceptibility to killing after penicil-
lin pretreatment in the absenceofcellular MPO activity. Specifically, whilekilling was
reduced slightly by inhibition ofMPO with azide or with MPO-deficient or CGD cells,
the penicillin enhancement was preserved. Furthermore, the addition ofscavengers of
superoxide dismutase (SOD) and H202, to the medium did not modify the ability of
cytochalasin B-treated normal cells to kill the staphylococci. Enhanced killing
following penicillin pretreatment was also found in the presence of both SOD and
catalase, a condition in which both 'G2 and OH formation by the Haber-Weiss
reaction would be impaired [27].
These findings imply that penicillin pretreatment of S. sanguis and S. aureus
augments the action of non-oxidative PMN microbicidal mechanisms against these
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organisms [28]. The nature ofthese mechanisms and their target(s) requires clarifica-
tion. In preliminary studies, the survival ofsubMIC penicillin pretreated staphylococci
atan acid pH was equivalent tountreated bacteria. Amildly increased susceptibility to
the action of lysozyme has been observed similar to findings reported in the past by
Warren and Gray [29]. Acooperative rolefor lyticserum complement factors has been
excluded [30]. The potential actionofantibacterial cationic proteins, perhaps acting in
cooperation with lysozyme, requires further evaluation [31].
Whatever the precise mechanisms involved, these studies demonstrate that antimi-
crobial effects against bacteria may profoundly alter their interaction with essential
host defense mechanisms beyond an ability to kill organisms or impair their growth.
This seems to be particularly true of compounds which modify bacterial surface
properties. The clinical implications ofthese findingsjustify further exploration ofthe
responsible mechanisms and an expansion ofthese approaches to other organisms and
other antimicrobial classes.
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